The term “regenerative medicine” is used to refer to methods to replace or regenerate human cells, tissues or organs to restore or establish normal function. This includes cell therapies, tissue engineering, gene therapy and biomedical engineering techniques, as well as more traditional treatments involving pharmaceuticals, biologics and devices.

In recent years it has grown in importance as a field of research for both biopharma and biotech, so much so that the market value is projected to reach $205.1 billion by 2035, according to analysts ResearchandMarkets.

Despite high costs and regulatory challenges, the sector continues to attract substantial investment and boosts to innovation through strategic collaborations among biotech firms, research institutions, and healthcare providers.

This eBook, sponsored by Thinkcyte, examines the latest advances in the sector and the market potential for regenerative medicine.

Download this exclusive eBook to learn more about:

• The latest clinical developments in regenerative medicine
• How we can use gene therapy to live longer, healthier lives
• Why regenerative medicine could be key to treating cardiac diseases
• How cancer has evolved from genetic disease to complex systemic condition

Get your eBook.